Eli Lil­ly adds a $15M eq­ui­ty sweet­en­er for its plat­form part­ner in saR­NA

The fa­ther-and-son team at Mi­NA Ther­a­peu­tics is on a roll.

Just weeks af­ter snag­ging a $25 mil­lion up­front and a trea­sure map with close to $1.25 bil­lion in mile­stones from Eli Lil­ly, the phar­ma gi­ant is back with a $15 mil­lion eq­ui­ty sweet­en­er.

A qui­et play­er for the first decade of its ex­is­tence, Mi­NA Ther­a­peu­tics has been rack­ing up deals and dol­lars in the past 2 years. In ad­di­tion to the Lil­ly pact, As­traZeneca signed up with the Im­pe­r­i­al Col­lege Lon­don spin­out along with Servi­er.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER